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Abstract 
 
Coronary Heart disease (CHD) is the biggest killer in the United Kingdom.  In 2018, over one 
quarter of deaths were due to CHD (British Heart Foundation, 2018), with congenital defects 
identified as the most common cause of heart disease in pregnancy (Wylie & Bryce, 2016).  
This article will focus on Marfan syndrome and the impact this has on pregnancy and 
childbirth.  Current literature and research will be appraised and discussed to explore mode 
of delivery during the second stage of labour and calculate the most appropriate method of 
delivery.  Additionally, this article will address how the midwife can further support women 
with Marfan syndrome during the pregnancy booking, antenatal period and intrapartum 
period without labelling them, and discuss how this may be achieved in relation to the 
uncertainty reduction communication theory. 
 
Marfan Syndrome 
 
Marfan syndrome (MFS) was first described by the French doctor Bernard J.A. Marfan in 
1896, and is a hereditary autosomal dominant disorder of connective tissue affecting 
collagen and elastin within a variety of body systems such as musculoskeletal, 
cardiovascular, respiratory, ocular and integumentary systems (Keane and Pyeritz, 2008). 
The Marfan Foundation (2018) states that the incidence of MFS in the UK population is 
approximately 18,000, with 200 new cases diagnosed every year in the UK and worldwide, 
statistics show that 1 in 3,300 are affected by MFS with approximately 50% of sufferers 
remaining undiagnosed.   
The disease process by which MFS presents itself, is identified by a mutation in the gene for 
fibrillin-1 on chromosome 15.  There are more than >1000 mutations and each one is unique 
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to an individual or family (Keane and Pyeritz, 2008). If one parent has MFS, there is a 50% 
risk of the fetus inheriting the mutant gene (Robson and Waugh, 2013).  Indeed, Gambling et 
al. (2008) further support this by examining the incidence of MFS, suggesting 25% of 
diagnosed cases arise as new mutation.  Consequently, this indicates further research would 
be beneficial, as the correlation between the genotype- phenotype of MFS is unclear due to 
the large number of unique mutations.   
 
There are a multitude of signs and symptoms of MFS; the visual appearance of a patient 
with the condition can present as tall, with a thin physique, very little subcutaneous fat and 
with an excessive length of long bones, long fingers and toes (Robson & Waugh, 2013). 
Also, Swan (2006) suggest that while both men and women are affected by the condition 
equally, it may appear more difficult to diagnose women as the appearance is less 
exaggerated than with their male counterparts.  This could lead to a plethora of 
complications if the woman was to enter pregnancy undiagnosed, as many symptoms of 
cardiac disease are similar to those of pregnancy, this will be discussed later in this paper. 
 
Associated general complications of MFS are outlined by Kumar & Clarke (2016) as being 
increased joint pain and possible dislocations due to the laxity of joints.  Additionally, those 
with MFS may encounter hernias, fatigue, and scoliosis of the spine leading to restrictions 
with mobility.  Also, spontaneous pneumothorax may be experienced in more than 10% of 
those affected with MFS. However, one of the most severe complications of the disease 
itself are cardiac complications.  The main concern of the cardiovascular system for those 
with MFS is the progressive enlargement of the aortic root diameter.  The measurement of 
the aortic root diameter is of great importance during pregnancy as Brooke et al (2008) 
suggests, as progressive enlargement of the aortic root can lead to dissection which 
accounts for 20% of maternal cardiac fatalities.  A normal aorta root diameter of the heart 
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measures between 20mm and 35mm but, as there is progressive enlargement of the aortic 
root with those affected with MFS, it is essential there is an early diagnosis of the condition 
so there is medical management within a detailed care plan.  Furthermore, it is crucial 
women with MFS receive regular echocardiography, a multi-disciplinary assessment and 
discussions regarding lifestyle choices such as healthy eating, exercise, and smoking 
cessation and these are addressed during pre-conception care, so the woman has achieved 
optimal health before embarking on pregnancy (Robson & Waugh, 2013).  Also, Pre-
conception counselling, genetic counselling and advice regarding treatments should be 
considered, so women are aware of the risks posed to her and her baby during the 
pregnancy, specifically as use of beta-blockers are advised throughout pregnancy to reduce 
aortic root dilatation (Marfan Foundation, 2018).    
 
Pregnancy Booking 
 
The role of the midwife in relation to cardiac disease in pregnancy is of upmost importance. 
The midwife must be aware of signs and symptoms related to cardiac problems throughout 
the pregnancy, and make referrals to other professionals within a multi-disciplinary team 
when necessary and as quickly and as effectively as possible without delay.  
 
Women who present at booking with a known cardiac problem must be considered high risk 
and therefore have shared care which includes the midwife, obstetrician, cardiologist and 
anaesthetist (Wylie & Bryce, 2016).  For women who present later in pregnancy with a 
suspected cardiac problem, diagnosis of the condition is usually based on tests such as 
blood tests, an electrocardiogram, echocardiography and chest X-rays all of which are 
considered safe in later pregnancy (Lewis & Drife, 2004).  Thus, the role of the midwife is to 
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take a comprehensive booking history and promptly make referrals to other health 
professionals.  Respiration and pulse must be monitored, as well as other vital observations 
at each antenatal visit, and women encouraged to take iron and vitamins to prevent anaemia 
which can induce additional stress on the heart due to lack of oxygen in the body (Burrow et 
al, 2004). 
 
Wylie & Bryce (2016) indicate the difficulty of recognising symptoms of cardiac problems in 
pregnancy, as pregnancy can produce ‘similar responses’ in the body’.  Therefore, the 
midwife must have full knowledge of the woman’s baseline observations so possible 
complications can be identified which are unrelated to pregnancy.  A New York Classification 
system (Table 1) was developed to identify the extent of heart failure which works by 
assessing the woman and placing her in one of four categories.  These categories are based 
on the woman’s limitations during physical activity and her symptoms, with regards to normal 
breathing, shortness of breath, angina pain and palpitations (Gambling et al. 2008). It could 
be considered the New York Classification system is a useful tool which could be used by 
midwives, to assist in identifying the degree of strain on the heart due to the additional 
workload during pregnancy. 
 
The impact of pregnancy has a significant risk on the compromised heart, and as suggested 
by O’Brien & Walker (2014) there are three periods during the childbearing process which 
are considered as critical.  Between 28-32 weeks gestation, there are haemodynamic 
changes which reach their peak during this stage in the pregnancy due to a 50% increase in 
blood volume, combined with the effects of pregnancy hormones which cause connective 
tissue changes and an increase of blood vessels throughout the uterus, all of which increase 
the workload of the heart.  Also, during labour there is an increase in cardiac output due to 
physical stress of uterine contractions and psychological stress of labour pain; and finally 12-
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24 hours postpartum is considered a critical period as additional blood volume from the 
uterus and placental site return to the systemic circulation.  Consequently, due to the 
increased cardiac output during these three critical periods, there is an increased risk of 
aortic dissection during pregnancy due to additional stress placed on the aortic root, and as 
suggested by Fujitani & Baldisseri (2005) 50% of aortic dissections in women occur during 
pregnancy. 
 
Although most women who present with cardiac disease can have a positive outcome of 
pregnancy according to Davis & Macnab (2016), in contrast Gambling et al. (2008) suggest 
those women who have an aortic root of more than 40mm should be advised against 
pregnancy irrespective of their New York Classification as they are at greater risk of aortic 
dissection.  An aortic root of more than 40mm carries a fatality rate of 36-72% within 48 
hours, and without intervention such as surgery or a chronic beta-blocker therapy, death will 
become imminent within one week.  Therefore, pre-conception advice and full physical 
examination are crucial for those with cardiac disease, alongside a detailed care plan which 
is regularly evaluated and updated within a multi-disciplinary team to ensure a positive 
outcome of pregnancy (Robson & Waugh, 2013).  
 
Furthermore, additional antenatal appointments should be arranged in consultation with the 
Obstetrian, ideally where all professionals are available in one clinic which would reduce the 
amount of visits required and advice given regarding compliance of prescribed drugs to 
avoid possible further complication (Kumar & Clark, 2016).  A pre-delivery anaesthetic 
assessment is recommended, as Gambling et al. (2008) suggest women with MFS can 
experience potential airway management problems due to cervical spine instability and a 
high arched palate.  Kumar & Clark (2016) also note, women should have regular 
echocardiograms at six week intervals to identify any changes to the aortic root diameter, 
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whilst according to a study by Rosenblum et al. (1983) even regular echocardiograms may 
fail to ‘predict’ aortic dissection in pregnancy for those women who have MFS.  However, the 
reliability of the Rosenblum et al. (1983) study could now be questioned as it is outdated and 
advances in technology now mean echocardiograms could be considered a good predictor 
of possible dissection (Burrow et al. 2004).  During the antenatal period, fetal growth will be 
regularly assessed by ultrasound, and an anomaly scan will be advised at 16-18 weeks 
gestation to detect for congenital abnormalities, as the risk of a cardiac defect is increased in 
these babies (Nanda et al., 2012).  Furthermore, it is suggested the midwife should advise 
the woman of possible premature labour and ruptured membranes as this is common with 
those who have MFS (Meijboom et al. 2006).   
 
Mode of Delivery and Intrapartum Care 
 
It is vitally important, a plan of care is made well in advance regarding mode of delivery, 
timing and type of analgesia and anaesthesia, and these decisions should be made within 
the multi-disciplinary team in discussion with the woman (Yu-Ling Tan, 2010).  During labour 
and delivery, there are significant haemodynamic changes which occur with each uterine 
contraction which can be tolerated by healthy women however, for those with heart disease 
it can result in morbidity and mortality.  This is due to a 300-500ml transfer of blood back into 
the systemic circulation with each contraction, in addition, alongside the anxiety of labour 
and the sympathetic response to pain, there is an increase in both heart rate and blood 
pressure therefore increasing cardiac output by 34% during contractions and 12% between 
contractions; this can lead to greater stress on the enlarged aortic root, ultimately increasing 
the risk of aortic dissection (Meijboom et al. 2006).  For this reason, it is important to 
examine a range of research and literature exploring vaginal delivery and caesarean section, 
to calculate the most appropriate method of delivery. 
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It has been suggested by Langesaeter et al. (2009), there is a greater focus on caesarean 
section as preferred mode of delivery rather than vaginal delivery.  Caesarean section can 
be advantageous in respect of date of delivery, and anaesthesia can be planned well in 
advance so further risk of damage or dissection to the aortic root can be avoided, however it 
could be questioned for who is it advantageous.  In a Dutch study by Meijboom et al. (2006) 
which investigated the obstetric maternal outcome of pregnancy in women with Marfan 
syndrome, it suggested out of the 122 enrolled women 31% had a caesarean section 
compared to the Dutch general population of 11% which questions whether the decision for 
caesarean section was in the best interests of the woman, or if the high rate of caesarean 
reflects fear and caution for further complications by obstetricians and cardiologists.  
Furthermore, the study did not take into consideration the woman’s New York classification 
of cardiovascular disease which further questions the reasons for opting for caesarean as it 
is suggested by Wylie & Bryce (2016) women who are considered to be class one or class 
two of the New York classification can often experience quick, uncomplicated labours and as 
long as the woman is given adequate analgesia to keep physiological and psychological 
stress minimised, a vaginal delivery can be achieved.  Moreover, Meijboom et al. (2006) 
suggest there are greater risks with caesarean such as fluctuations of blood pressure as a 
result of intubation and anaesthetic agent for those who require general anaesthetic; 
increased risk of wound and uterine infection, also greater risk of venous thromboembolism 
and increased blood loss compared with vaginal delivery. However, Langesaeter et al. 
(2009) defends caesarean and suggests it is the safest mode of delivery as haemodynamic 
stability can be achieved through use of regional anaesthesia such as epidural, as cardiac 
output is decreased therefore causing vasodilation which reduces venous resistance, 
alongside use of intravenous doses of oxytocin and invasive monitoring such as an arterial 
line. 
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According to Richards & Yentis (2006), vaginal delivery is the safest mode of delivery as it 
causes less stress to the heart however, there are a number of considerations to be taken 
into account when a vaginal delivery is planned.  During the first stage of labour, it is 
advisable for the woman to remain in an upright or left lateral position to prevent aortocaval 
compression therefore displacing the uterus away from the aorta and vena cava.  However 
most importantly, directed pushing during the second stage of labour must not be 
encouraged as this causes a decrease and sometimes a complete loss in cardiac output 
which cannot be restored (Richards & Yentis, 2006).  Robson & Waugh (2013) could be 
criticised for suggesting directed pushing during the second stage of labour, as they fail to 
question the consequences of such an action in relation to the stress it would place upon the 
heart, therefore leading to possible aortic dissection which consequently accounts for 20% of 
maternal cardiac fatalities (Swan, 2006).  Furthermore, Robson & Waugh (2013) fail to 
provide evidence to support their recommendation of directed pushing in relation to women 
with cardiac disease in pregnancy.  Also, it is important to note, some women may require 
an assisted vaginal delivery whereby Meijboom et al. (2006) suggests vacuum or forceps be 
used, so long as effective analgesia was utilised such as epidural early in labour, as this 
would minimise physiological stress and outweigh any risk compared with those of 
caesarean section. 
 
Following analysis of a range of material in support of both vaginal delivery and caesarean 
section, it could be argued the most appropriate mode of delivery is vaginal delivery with 
spontaneous pushing and if required, with aid of instrumental delivery as the risks 
associated with this outweigh any risk associated with caesarean section.  However, it is 
important to highlight women with cardiac disease in pregnancy, must always give birth in an 
obstetric unit where all professionals within the multi-disciplinary team are available.  Also, 
close monitoring of vital signs is crucial, alongside use of an echocardiography throughout 
labour and someone who can interpret the findings, likewise, oxygen therapy should be 
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available if required, as well as close monitoring of fluid balance through the use of a central 
venous pressure catheter if necessary (Roberts & Ketchell, 2012).  Furthermore, it was 
found when analysing mode of delivery, there does not seem to be a definite appropriate 
method as most of the research and articles contradicted one another, which indicates the 
decision of mode of delivery needs to be made in relation to individual circumstances in 
discussion with the woman. 
 
How Can Midwives Support Women? 
 
Caring for women with cardiac disease in pregnancy can be considered outside the 
parameters of the midwife and a need for referral to other practitioners is essential.  
Moreover, as expressed by the NMC (2018) the midwife will continue to give care as part of 
a team and will need to be aware of any cardiac compromise throughout pregnancy and 
childbirth.  Therefore, it could be questioned how midwives can best support women with 
cardiac disease.   
 
Within midwifery practice, women-centred care remains paramount and so the midwife 
should encourage a two-way transfer of knowledge and information at each contact. This 
would ensure a trusting relationship with the woman, so midwives are able to organise a 
plan of care based on the information she herself has knowledge of.  Also, the importance of 
gradually ‘drip-feeding’ new information to the woman is essential, so she is able to acquire 
her own knowledge which will empower her to make decisions about her own care, and 
allow her to prepare for critical periods during pregnancy and childbirth. 
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According to West & Turner (2018) uncertainty can cause stress and anxiety, so by 
examining communication theories, in particular the uncertainty reduction theory in seminal 
literature by Berger (1979), it can be understood that good communication is the foundation 
of how midwives can support women with heart disease.  It is thought, “One of the 
motivations underpinning interpersonal communication is the acquisition of information with 
which to reduce uncertainty” (Heath and Bryant, 2013, p.259). Thus, it is vital midwives 
discuss all options concerning care with women and include them in decision making; they 
act as an advocate for them, and offer information so they can make an informed decision, 
to prepare them for the possible need of hospital care in the third trimester of pregnancy.  It 
can be considered difficult when trying to normalise pregnancy for women with heart disease 
without labelling them.  Therefore, it is important the woman is invited to parent craft classes 
alongside other pregnant women so she feels included, whereby health promotion can be 
discussed with everyone such as the advantages of a well-balanced diet and controlling 
weight gain, regardless of the fact she may have already discussed this with another 
professional involved in her care. 
 
Conclusion 
 
In conclusion, a multi-disciplinary approach is essential for successful management of those 
who present in pregnancy with cardiovascular disease.  Also, the midwife must be aware of 
the signs and symptoms of CHD for those women who are unaware they have a cardiac 
problem and make immediate referrals to other professionals.  The New York Classification 
of cardiovascular disease is a useful tool which can be used by midwives, to inform practice 
by alerting them to any additional stress which is placed on the heart.  Women-centred care 
is essential within midwifery practice and by sharing knowledge and information of MFS with 
the woman, midwives and other health professionals are able to organise a plan of care 
11 
 
through joint decision-making, which in turn will empower her and prepare her for critical 
periods during pregnancy and childbirth. In general, vaginal delivery with epidural analgesia 
is the preferred mode of delivery compared with caesarean section as there are fewer risks 
and haemodynamic stability can be achieved.  Moreover, by examining communication 
theories such as the uncertainty reduction theory, it was found good communication is the 
foundation of the support midwives can give to women who have cardiovascular problems in 
pregnancy and by inviting these women to sessions such as parent craft to discuss health 
promotion as a larger group, it may help women feel included, therefore attempting to 
normalise her pregnancy. 
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New York Classification of Cardiovascular Disease. 
Classification Patient Characteristics 
Class One: No objective 
evidence of cardiovascular 
disease. 
Patients with cardiac disease but without resulting 
limitation of physical activity.  Ordinary physical activity in 
the patient does not cause fatigue, palpitation, dyspnoea or 
angina. 
Class Two: Objective 
evidence of minimal 
cardiovascular disease. 
Patients with cardiac disease resulting in slight limitation of 
physical activity.  The patient is comfortable at rest.  
Ordinary physical activity results in fatigue, palpitation, 
dyspnoea or angina. 
Class Three: Objective 
evidence of moderately 
severe cardiovascular 
disease. 
Patients with cardiac disease resulting in marked limitation 
of physical activity.  They are comfortable at rest. Less 
than ordinary activity causes fatigue, palpitation, dyspnoea 
or angina. 
Class Four: Objective 
evidence of severe 
cardiovascular disease. 
Patients with cardiac disease resulting in an inability to 
carry on any physical without discomfort. Symptoms of 
heart failure or angina may be present even when the 
patient is at rest.  If physical activity is undertaken, 
discomfort increases. 
Adapted from Wylie & Bryce (2016) The Midwives Guide to Key Medical Conditions. 
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Key points: 
 
•  Marfan syndrome in the UK incidence of approximately 18000, with 200 new cases 
diagnosed every year in the UK. 
•  A plethora of complications can occur if a woman was to enter pregnancy with heart 
disease undiagnosed, as many symptoms are similar to those of pregnancy. 
•  It is suggested, the most appropriate mode of delivery is vaginal delivery, as the risks 
associated with this outweigh any risk associated with caesarean section. 
•  Women with coronary heart disease in pregnancy may feel excluded due to medicalisation 
of her care.  Midwives can support women and help inclusion by inviting them to parent craft 
sessions to discuss health promotion as a larger group, therefore attempting to ‘normalise’ 
her pregnancy. 
 
Reflective Questions: 
 
•  How would you ensure women with CHD feel empowered during their pregnancy? How 
would you advocate for her whilst in your care? 
•  How would you support women with CHD who could potentially decline/ not attend regular 
medical appointments with multidisciplinary colleagues during pregnancy? 
•  What is your referral pathway, if you suspect a woman in your care presents with cardiac 
problems? Could you recognise these alongside normal pregnancy symptoms?  How would 
you express your concerns to the woman without distressing her? 
